Marc H Levin1, Gregory T Armstrong2, Julian H Broad3, Robert Zimmerman4, Larissa T Bilaniuk5, Tamara Feygin4, Yimei Li6, Grant T Liu7, Michael J Fisher8. 1. Division of Ophthalmology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA Department of Ophthalmology, University of California San Francisco, San Francisco, California, USA. 2. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. 3. Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 4. The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA Department of Radiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 5. The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA Department of Radiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 6. Department of Biostatistics and Epidemiology, The University of Pennsylvania, Philadelphia, Pennsylvania, USA. 7. Division of Ophthalmology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. 8. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abstract
BACKGROUND/AIMS: Optic nerve tortuosity and nerve and sheath thickening are observed on MRI in some patients with neurofibromatosis type 1 (NF-1). This study aimed to determine if tortuosity and thickening are associated with the development of optic pathway glioma (OPG) and subsequent vision loss. METHODS: Children with NF-1 who underwent brain MRI between 1992 and 2005, and had at least 1 year of subsequent visual acuity (VA) follow-up, were identified retrospectively. The baseline MRI was independently reviewed by three neuroradiologists for consensus assessment. Tortuosity was identified using validated operational criteria. Optic nerve and sheath thicknesses and VA at last follow-up were directly measured. RESULTS: Of 132 evaluable children, seven (5%) had tortuosity on baseline MRI. 20 subjects (15%) ultimately developed OPG at a median of 1.9 years (range 7 months-8.0 years) following the baseline MRI. Subjects with tortuosity were significantly more likely to develop OPG than those without tortuosity (57% vs 13%, p=0.01). In subjects who developed OPG, the prevalence of tumour-related vision loss was not significantly different between those with and without baseline tortuosity (14% vs 4%, p=0.28). No difference existed between mean baseline optic nerve (2.3 vs 2.2 mm) or sheath (5.2 vs 5.4 mm) thicknesses comparing subjects who did and did not develop OPG. CONCLUSIONS: Optic nerve tortuosity at baseline is associated with OPG development among patients with NF-1, but does not predispose to aggressive OPG with associated vision loss. Neither nerve nor sheath thickening at baseline is associated with OPG development. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND/AIMS: Optic nerve tortuosity and nerve and sheath thickening are observed on MRI in some patients with neurofibromatosis type 1 (NF-1). This study aimed to determine if tortuosity and thickening are associated with the development of optic pathway glioma (OPG) and subsequent vision loss. METHODS:Children with NF-1 who underwent brain MRI between 1992 and 2005, and had at least 1 year of subsequent visual acuity (VA) follow-up, were identified retrospectively. The baseline MRI was independently reviewed by three neuroradiologists for consensus assessment. Tortuosity was identified using validated operational criteria. Optic nerve and sheath thicknesses and VA at last follow-up were directly measured. RESULTS: Of 132 evaluable children, seven (5%) had tortuosity on baseline MRI. 20 subjects (15%) ultimately developed OPG at a median of 1.9 years (range 7 months-8.0 years) following the baseline MRI. Subjects with tortuosity were significantly more likely to develop OPG than those without tortuosity (57% vs 13%, p=0.01). In subjects who developed OPG, the prevalence of tumour-related vision loss was not significantly different between those with and without baseline tortuosity (14% vs 4%, p=0.28). No difference existed between mean baseline optic nerve (2.3 vs 2.2 mm) or sheath (5.2 vs 5.4 mm) thicknesses comparing subjects who did and did not develop OPG. CONCLUSIONS:Optic nerve tortuosity at baseline is associated with OPG development among patients with NF-1, but does not predispose to aggressive OPG with associated vision loss. Neither nerve nor sheath thickening at baseline is associated with OPG development. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery Journal: J Neuroophthalmol Date: 2017-09 Impact factor: 3.042
Authors: Robert A Avery; Awais Mansoor; Rabia Idrees; Elijah Biggs; Mohammad Ali Alsharid; Roger J Packer; Marius George Linguraru Journal: Neurology Date: 2016-05-11 Impact factor: 9.910
Authors: Jared M Pisapia; Hamed Akbari; Martin Rozycki; Jayesh P Thawani; Phillip B Storm; Robert A Avery; Arastoo Vossough; Michael J Fisher; Gregory G Heuer; Christos Davatzikos Journal: Neurooncol Adv Date: 2020-08-01
Authors: Laura Sellmer; Said Farschtschi; Marco Marangoni; Manraj K S Heran; Patricia Birch; Ralph Wenzel; Victor-Felix Mautner; Jan M Friedman Journal: Orphanet J Rare Dis Date: 2018-04-23 Impact factor: 4.123